Saratoga Health & Biotechnology I's Average Process Pillar and People Pillar ratings hold this strategy's Morningstar Quantitative Rating of Neutral. Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the highest quintile among peers.
- NAV / 1-Day Return 23.21 / 0.73 %
- Total Assets 12.7 Mil
-
Adj. Expense Ratio
- Expense Ratio 2.500%
- Distribution Fee Level High
- Share Class Type Institutional
- Category Health
- Investment Style Large Blend
- Min. Initial Investment 250
- Status Open
- TTM Yield 0.00
- Turnover 23%
Morningstar’s Analysis SBHIX
Will SBHIX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.